Tenet Healthcare Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports the results of the 2026 Annual Meeting of Shareholders held on May 27, 2026. The filing covers the election of directors, advisory approval of executive compensation, and ratification of independent auditors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following matters were submitted to a vote of security holders:
- Director Elections: All 12 nominees were elected to the Board of Directors. Notable vote counts included Saumya Sutaria (72,297,676 For) and J. Robert Kerrey (71,837,362 For). Broker non-votes totaled 5,510,667 for all director proposals.
- Executive Compensation: Shareholders approved the advisory vote on executive compensation with 62,554,346 votes For and 11,817,273 votes Against.
- Auditor Ratification: Shareholders approved the selection of Deloitte & Touche LLP as the independent registered public accountants for the year ending December 31, 2026, with 79,422,386 votes For and 470,477 votes Against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the final composition of the Board of Directors following the May 27, 2026 election.
- Review the proxy statement for details on the specific executive compensation package approved by shareholders.
- Confirm the engagement terms with Deloitte & Touche LLP for the 2026 fiscal year.
- Check subsequent filings for any financial updates or operational changes not included in this governance report.